Rosiglitazone indications: Difference between revisions
Jump to navigation
Jump to search
Matt Pijoan (talk | contribs) m Reverted edits by AkylazGiE1 (talk) to last revision by NNethala |
m Protected "Rosiglitazone indications" ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
(No difference)
| |
Latest revision as of 17:30, 20 December 2011
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Indications
AVANDIA is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus.
- AVANDIA is indicated as monotherapy.
- AVANDIA is also indicated for use in combination with a sulfonylurea, metformin, or insulin when diet, exercise, and a single agent do not result in adequate glycemic control. For patients inadequately controlled with a maximum dose of a sulfonylurea or metformin, AVANDIA should be added to, rather than substituted for, a sulfonylurea or metformin.
- AVANDIA is also indicated for use in combination with a sulfonylurea plus metformin when diet, exercise, and both agents do not result in adequate glycemic control.
Adapted from the FDA Package Insert.